Literature DB >> 15821647

Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors.

Yasushi Shintani1, Mitsunori Ohta, Masato Minami, Hiroyuki Shiono, Hirohisa Hirabayashi, Masayoshi Inoue, Goro Matsumiya, Hikaru Matsuda.   

Abstract

OBJECTIVE: We sought to investigate the correlation between type of vascular reconstruction and long-term graft patency after replacement of brachiocephalic veins combined with resection of mediastinal malignancies.
METHODS: Eighteen patients underwent surgical resection of tumors and the superior vena cava with concomitant vascular reconstruction using ringed polytetrafluoroethylene grafts. Graft patency was verified by means of venography or contrast-enhanced computed tomography at time points ranging from 3 to 77 months (median, 33 months) postoperatively.
RESULTS: Seven patients underwent sole reconstruction of the right brachiocephalic vein, with occlusion observed in only 1 patient. In 6 patients who underwent reconstruction of the bilateral brachiocephalic veins with 2 separate grafts, the grafts remained patent in 2, whereas 4 patients experienced occlusion of one of the two grafts yet remained asymptomatic. Both patients who underwent reconstruction with a Y graft experienced left brachiocephalic vein graft occlusion. In the 3 patients who underwent reconstruction of a left brachiocephalic vein, the graft became occluded, and superior vena cava syndrome developed in 2 of these patients.
CONCLUSION: When replacing the superior vena cava, reconstruction of a left brachiocephalic vein alone results in a significant rate of occlusion and development of superior vena cava syndrome. Thus we advocate sole right brachiocephalic vein reconstruction or bilateral brachiocephalic vein reconstruction in this setting, and separate reconstruction of the veins is preferable to use of a Y graft.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821647     DOI: 10.1016/j.jtcvs.2004.05.001

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

Review 1.  Surgical management of thymic epithelial tumors.

Authors:  Yasushi Shintani; Soichiro Funaki; Naoko Ose; Takashi Kanou; Eriko Fukui; Kenji Kimura; Masato Minami
Journal:  Surg Today       Date:  2020-07-10       Impact factor: 2.549

2.  Analysis of surgical treatment of Masaoka stage III-IV thymic epithelial tumors.

Authors:  Kazutoshi Hamanaka; Tsutomu Koyama; Shunichiro Matsuoka; Tetsu Takeda; Kentaro Miura; Kyoko Yamada; Akira Hyogotani; Tatsuichiro Seto; Kenji Okada; Ken-Ichi Ito
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-08-21

3.  Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion.

Authors:  Geun Dong Lee; Hyeong Ryul Kim; Se Hoon Choi; Yong-Hee Kim; Dong Kwan Kim; Seung-Il Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

4.  Temporary bypass for superior vena cava reconstruction with Anthron bypass tubeTM.

Authors:  Keitaro Matsumoto; Naoya Yamasaki; Tomoshi Tsuchiya; Takuro Miyazaki; Ryotaro Kamohara; Go Hatachi; Takeshi Nagayasu
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Patency of grafts after total resection and reconstruction of the superior vena cava for thoracic malignancy.

Authors:  Hiroaki Oizumi; Kenji Suzuki; Takamitsu Banno; Takeshi Matsunaga; Shiaki Oh; Kazuya Takamochi
Journal:  Surg Today       Date:  2016-06-14       Impact factor: 2.549

Review 6.  Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart.

Authors:  Yugo Tanaka; Daisuke Hokka; Hiroyuki Ogawa; Nahoko Shimizu; Takeshi Inoue; Hiroshi Tanaka; Yutaka Okita; Yoshimasa Maniwa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-05-24

Review 7.  Is it safe to divide and ligate the left innominate vein in complex cardiothoracic surgeries?

Authors:  Arthur McPhee; Kasra Shaikhrezai; Geoffrey Berg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-04

8.  Is postoperative anticoagulation necessary after left innominate vein division in general thoracic surgery?

Authors:  Hironobu Hoshino; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-10-29

9.  Superior vena cava (SVC) reconstruction using autologous tissue in two cases of differentiated thyroid carcinoma presenting with SVC syndrome.

Authors:  Nobuyuki Wada; Katsuhiko Masudo; Shohei Hirakawa; Tetsukan Woo; Hiromasa Arai; Nobuyasu Suganuma; Hideyuki Iwaki; Norio Yukawa; Keiichi Uchida; Kiyotaka Imoto; Yasushi Rino; Munetaka Masuda
Journal:  World J Surg Oncol       Date:  2009-10-13       Impact factor: 2.754

10.  Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases.

Authors:  Erkan Kaba; Berker Özkan; Mehmet Oğuzhan Özyurtkan; Kemal Ayalp; Alper Toker
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.